Botanical species · safety record

Kaempferia parviflora

The EFSA Compendium of Botanicals holds 1 constituent measurement and 4 adverse-effect records for Kaempferia parviflora. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Kaempferia parviflora Wall. Ex. Baker

1Constituent measurements

4Safety records

4Cited sources

21Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 21 licensed products naming Kaempferia parviflora as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

Rhizome
Root

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
1,8-cineole	Roots and other underground parts	Solvent extraction	1.26 Percent Area	GC-MS	Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Endocrine	Urogenital	Roots and other underground parts	Drying (dehydration)	Rat (as animal)	Reproduction toxicity	Resolve DOI
Hepatotoxicity	Liver	Roots and other underground parts	Solvent extraction	Rat (as animal)	Subchronic	No resolvable identifier
Other toxicities	—	Roots and other underground parts	Solvent extraction	Rat (as animal)	Chronic/long term toxicity	No resolvable identifier
Other toxicities	—	Roots and other underground parts	Solvent extraction	Rat (as animal)	Chronic/long term toxicity	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Chivapat, Songpol., Chavalittumrong, Pranee., Attawish, Aimmanas., Rungsipipat, Anudep. Chronic Toxicity Study of Kaempferia parviflora Wall ex. Extract. Thai journal of veterinary medicine, 2010, vol. 40, no. 4, p. 377-383.
Pripdeevech, Patcharee., Pitija, Kitsada., Rujjanawate, Chaiyong., Pojanagaroon, Sermsakul., Kittakoop, Prasat., Wongpornchai, Sugunya. Adaptogenic-active components from Kaempferia parviflora rhizomes. Food chemistry, 2012, vol. 132, no. 3, p. 1150-1155. DOI
Trisomboon, Hataitip., Watanabe, Gen., Wetchasit, Phongphat., Taya, Kazuyoshi. Effect of daily treatment with Thai herb, Kaempferia parviflora, in Hershberger assay using castrated immature rats . Journal of reproduction and development, 2007, vol. 53, no. 2, p. 351-356. DOI
Sudwan, Paiwan., Saenphet, Kanokporn., Saenphet, Supap., Suwansirikul, Songkiet. Effect of Kaempferia parviflora Wall. ex. Baker on sexual activity of male rats and its toxicity. . The southeast asian journal of tropical medicine and public health, 2006, vol. 37 Suppl 3, p. 210-5.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature